Fresenius Medical Care Appoints Cassie McLean to Management Board to Lead Global Care Delivery Operations
Fresenius Medical Care AG, the world’s leading provider of products and services for people living with kidney disease, has announced the appointment of Cassie McLean as a member of its Management Board, effective August 1, 2026. In her new position, McLean will serve as Chief Executive Officer of the Care Delivery operating segment, assuming responsibility for one of the company’s most strategically important business units.
The appointment represents a significant leadership transition for Fresenius Medical Care as it continues executing its long-term transformation strategy, known as FME Reignite, aimed at strengthening operational performance, improving financial results, enhancing patient care, and driving sustainable growth across its global dialysis network.
McLean succeeds Craig Cordola, who previously served as Chief Executive Officer of Care Delivery. The company expressed appreciation for Cordola’s leadership and contributions to Fresenius Medical Care’s global patient care operations while welcoming McLean to the executive leadership team.
With extensive experience in kidney care, healthcare operations, and executive leadership, McLean is expected to play a central role in advancing Fresenius Medical Care’s strategic priorities while further strengthening the organization’s position as a global leader in renal care.
Leadership Transition Reflects Strategic Priorities
The appointment of Cassie McLean comes at an important time for Fresenius Medical Care as the organization continues optimizing its global operating model.
According to the company, the Care Delivery leadership role has been redesigned to establish more direct accountability for both operational execution and overall business performance.
By streamlining leadership responsibilities, Fresenius Medical Care aims to accelerate decision-making, strengthen operational oversight, and improve execution across its extensive global network of dialysis clinics.
The updated organizational structure aligns with broader efforts to enhance efficiency while maintaining the company’s longstanding commitment to delivering high-quality patient care.
Expanding Responsibilities
In her new role, McLean will oversee Fresenius Medical Care’s worldwide Care Delivery business.
Her responsibilities include direct leadership of:
- Fresenius Kidney Care in the United States
- Care Delivery International operations
- Global dialysis clinic performance
- Operational excellence initiatives
- Financial performance
- Patient care delivery
- Clinical operations
- Strategic growth initiatives
The expanded role places McLean in charge of one of the largest kidney care delivery organizations in the world, serving hundreds of thousands of patients across numerous countries.
Her leadership will influence clinical operations, business performance, workforce development, and patient experience throughout the company’s international care network.
Building on Previous Leadership at Fresenius Medical Care
McLean joined Fresenius Medical Care in August 2025 as President of Fresenius Kidney Care, the company’s U.S. dialysis services business.
During her first year with the organization, she focused on improving operational performance while strengthening accountability across clinic operations.
According to company leadership, she successfully introduced new organizational structures, enhanced operational visibility, and implemented management tools designed to improve execution throughout the U.S. clinic network.
These initiatives have helped establish a stronger operational foundation while supporting the broader objectives of the FME Reignite transformation strategy.
Her performance in this role contributed to the decision to expand her responsibilities through appointment to the Management Board.
Confidence from the Supervisory Board
Michael Sen, Chairman of the Supervisory Board of Fresenius Medical Care, welcomed McLean to the company’s executive leadership team.
He highlighted her extensive dialysis expertise, leadership capabilities, and comprehensive understanding of the operational factors driving performance within the clinic business.
According to Sen, the Supervisory Board believes McLean possesses the experience and leadership qualities necessary to accelerate progress throughout the Care Delivery organization.
Her appointment reflects the Board’s confidence in her ability to continue improving operational performance while supporting the company’s long-term strategic objectives.
Sen also expressed appreciation for the contributions made by outgoing Care Delivery CEO Craig Cordola, thanking him for his commitment to patients and wishing him continued success in his future endeavors.
Support from Executive Leadership
Helen Giza, Chief Executive Officer and Chair of the Management Board of Fresenius Medical Care, also praised McLean’s accomplishments since joining the company.
Giza noted that McLean moved quickly to strengthen the U.S. clinic business by increasing operational transparency, implementing improved organizational structures, introducing accountability-focused management tools, and reinforcing leadership talent throughout the organization.
These efforts, according to Giza, have positioned the Care Delivery business for continued progress as Fresenius Medical Care pursues its operational and financial objectives.
She expressed confidence that McLean will successfully execute the company’s strategy while helping achieve its medium-term financial goals.
Focus on the FME Reignite Strategy
In accepting her new role, McLean emphasized the importance of Care Delivery within Fresenius Medical Care’s broader transformation strategy.
The FME Reignite initiative serves as the company’s roadmap for improving operational performance while strengthening long-term competitiveness.
The strategy focuses on several key priorities, including:
- Enhancing operational efficiency
- Driving sustainable financial performance
- Improving patient outcomes
- Strengthening organizational accountability
- Supporting innovation
- Investing in workforce development
- Delivering profitable long-term growth
As leader of the Care Delivery segment, McLean will play a central role in executing these initiatives across the company’s global dialysis network.
Priorities for the Care Delivery Business
McLean outlined several immediate priorities that will guide the Care Delivery organization.
Among the most important objectives is improving same-market treatment growth across the United States.
Same-market growth measures expansion within existing clinic operations rather than growth through acquisitions or new facilities.
Improving this metric reflects stronger patient retention, increased operational effectiveness, and enhanced utilization of existing healthcare infrastructure.
Additional priorities include advancing operational performance while ensuring sustainable financial growth without compromising quality of care.
Maintaining high standards of patient care remains central to the organization’s mission.
Continuing Commitment to Patients
Throughout her remarks, McLean emphasized that patients remain at the center of every strategic decision.
Fresenius Medical Care operates one of the world’s largest dialysis networks, providing life-sustaining treatment for individuals living with chronic kidney disease and end-stage kidney disease.
These patients often require dialysis several times each week throughout their lives or until receiving a kidney transplant.
Delivering consistent, high-quality care therefore requires exceptional operational coordination across thousands of healthcare professionals, clinics, and support services.
McLean indicated that maintaining this commitment while improving operational performance will remain a defining priority.
Extensive Experience in Kidney Care
Before joining Fresenius Medical Care, McLean built an extensive career in healthcare leadership.
Most recently, she served as Chief Executive Officer of Monte Nido, a leading behavioral healthcare organization specializing in the treatment of eating disorders.
In that role, she gained valuable experience leading a large healthcare organization while overseeing clinical operations, organizational growth, and patient-centered care initiatives.
Her background combines expertise in both specialty healthcare services and operational management.
Nearly Sixteen Years at DaVita Kidney Care
Prior to leading Monte Nido, McLean spent nearly 16 years at DaVita Kidney Care, one of the largest kidney care organizations in the United States.
During her tenure, she held numerous leadership positions of increasing responsibility.
Among these was the role of Group Vice President, where she managed large operational teams while helping oversee dialysis clinic performance and patient care initiatives.
Her long career within the kidney care sector has provided extensive knowledge of:
- Dialysis operations
- Clinical quality
- Patient engagement
- Healthcare workforce management
- Financial performance
- Regulatory compliance
- Operational improvement
This experience positions her well to lead Fresenius Medical Care’s global clinic business.
Academic Background
McLean’s leadership experience is complemented by a strong academic foundation in healthcare administration and science.
She earned a Master of Public Administration in Healthcare Finance from New York University, providing advanced expertise in healthcare management, finance, and public policy.
She also holds a Bachelor of Science in Biology from Colorado College, giving her a scientific understanding that complements her operational leadership experience.
This combination of scientific education and executive healthcare management has supported her career across multiple healthcare organizations.
The Importance of Care Delivery
Care Delivery represents one of Fresenius Medical Care’s largest and most important operating segments.
The business oversees direct patient care through a global network of dialysis clinics serving individuals with kidney disease.
Services provided include:
- Hemodialysis
- Home dialysis support
- Chronic kidney disease management
- Clinical monitoring
- Patient education
- Care coordination
- Nutritional counseling
- Multidisciplinary kidney care
The organization works closely with nephrologists, nurses, dietitians, social workers, and other healthcare professionals to deliver comprehensive renal care.
Maintaining consistent quality across such an extensive international network requires strong leadership and operational discipline.
Responding to Growing Healthcare Demand
The demand for kidney care services continues increasing globally.
Several long-term factors contribute to this trend, including:
- Aging populations
- Rising diabetes prevalence
- Increasing hypertension rates
- Growth in chronic kidney disease
- Improved patient survival
- Greater access to dialysis therapy
These trends create growing demand for organizations capable of delivering efficient, high-quality renal care at scale.
Fresenius Medical Care continues investing in operational improvements, workforce development, and innovative care models to address these evolving healthcare needs.
McLean’s leadership will play an important role in helping the organization respond effectively to these long-term market dynamics.
Driving Sustainable Growth
Beyond operational excellence, McLean will also focus on supporting sustainable financial performance.
Healthcare organizations increasingly balance multiple priorities, including:
- Clinical quality
- Patient satisfaction
- Cost management
- Workforce engagement
- Regulatory compliance
- Technology investment
- Long-term growth
Successfully managing these priorities requires disciplined leadership capable of aligning operational execution with strategic objectives.
The company’s revised leadership structure aims to strengthen this alignment while accelerating performance improvements.
Cassie McLean’s appointment to the Management Board marks an important step in Fresenius Medical Care’s ongoing transformation as it continues advancing its FME Reignite strategy. Drawing on extensive experience in kidney care, healthcare operations, and executive leadership, she brings a strong combination of clinical understanding, operational expertise, and strategic vision to one of the company’s most critical leadership positions.
As Chief Executive Officer of the Care Delivery operating segment, McLean will oversee Fresenius Medical Care’s global dialysis clinic business while focusing on improving operational execution, strengthening financial performance, expanding same-market treatment growth, and maintaining the high standards of patient care that define the organization. Supported by the confidence of both the Supervisory Board and executive leadership, her appointment positions Fresenius Medical Care to continue delivering innovative, patient-centered kidney care while pursuing sustainable long-term growth across its global healthcare network.
Source link: https://freseniusmedicalcare.com/
